Literature DB >> 9098561

Brain injury after hypoxia-ischemia in newborn rats: relationship to extracellular levels of excitatory amino acids and cysteine.

M Puka-Sundvall1, M Sandberg, H Hagberg.   

Abstract

The aim of this study was to follow extracellular concentrations of excitatory amino acids (EAAs) and cysteine during neonatal hypoxia-ischemia (HI) and reflow and to relate these events to the extent of brain damage evaluated 6 h after the insult. Rat pups (PND 7-10) were subjected to unilateral ligation of the common carotid artery and exposed to hypoxia (7.7% O2). Extracellular amino acids were sampled during HI and for 6 h of reperfusion with microdialysis and the levels were correlated with the extent of brain damage at the site of probe placement. The concentrations of glutamate, aspartate and cysteine increased transiently during HI (15 x, 6 x and 3 x, respectively) in the extracellular space and returned to normal or remained slightly elevated during reperfusion. Changes of EAAs and cysteine were similar during HI in the infarcted, undamaged and border-zone regions. During reperfusion the concentrations of glutamate, aspartate and cysteine were higher in infarcted and border-zone areas compared to undamaged tissue. In neonatal rats, the extracellular levels of EAAs during HI do not correspond to the extent of brain injury whereas the EAA concentrations during reflow are related to the extent of infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098561     DOI: 10.1016/s0006-8993(97)00024-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Release of endogenous amino acids from the striatum from developing and adult mice in ischemia.

Authors:  Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2011-04-13       Impact factor: 3.996

2.  Intranasal basic fibroblast growth factor attenuates endoplasmic reticulum stress and brain injury in neonatal hypoxic-ischaemic injury.

Authors:  Zhenlang Lin; Yingying Hu; Zhouguang Wang; Shulin Pan; Hao Zhang; Libing Ye; Hongyu Zhang; Mingchu Fang; Huai Jiang; Junming Ye; Jian Xiao; Li Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 3.  Glucose and Intermediary Metabolism and Astrocyte-Neuron Interactions Following Neonatal Hypoxia-Ischemia in Rat.

Authors:  Eva Brekke; Hester Rijkje Berger; Marius Widerøe; Ursula Sonnewald; Tora Sund Morken
Journal:  Neurochem Res       Date:  2016-12-26       Impact factor: 3.996

4.  The pentose phosphate pathway and pyruvate carboxylation after neonatal hypoxic-ischemic brain injury.

Authors:  Eva M F Brekke; Tora S Morken; Marius Widerøe; Asta K Håberg; Ann-Mari Brubakk; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

Review 5.  Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection.

Authors:  Mir Ahamed Hossain
Journal:  Int J Dev Neurosci       Date:  2007-09-07       Impact factor: 2.457

6.  Early metabolite changes after melatonin treatment in neonatal rats with hypoxic-ischemic brain injury studied by in-vivo1H MR spectroscopy.

Authors:  Hester Rijkje Berger; Axel K G Nyman; Tora Sund Morken; Riyas Vettukattil; Ann-Mari Brubakk; Marius Widerøe
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

7.  Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses.

Authors:  Yong-Hong Yi; Wen-Chao Guo; Wei-Wen Sun; Tao Su; Han Lin; Sheng-Qiang Chen; Wen-Yi Deng; Wei Zhou; Wei-Ping Liao
Journal:  Biologics       Date:  2008-06

8.  Does Levetiracetam Administration Prevent Cardiac Damage in Adulthood Rats Following Neonatal Hypoxia/Ischemia-Induced Brain Injury?

Authors:  Serkan Gurgul; Belgin Buyukakilli; Mustafa Komur; Cetin Okuyaz; Ebru Balli; Tuba Ozcan
Journal:  Medicina (Kaunas)       Date:  2018-04-10       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.